Five year clinical follow-up of the PASSION-trial Five year clinical follow-up of the PASSION-trial Five Year Follow-up after Primary PCI with a Paclitaxel-Eluting.
Predictors of Acute, Subacute and Late Stent Thrombosis After Acute MI Primary Angioplasty in the Horizons AMI Trial George D. Dangas, Alexandra J. Lansky,
I International Symposium on Prevention of Cardiovascular Diseases Kraków 9-11.06.2005 Prevention of Heart Failure after AMI MAŁOPOLSKA STUDY A 2256-Patients.
Should we dilate the non- infarct related arteries in patients with multi-vessel disease? Carma Karam, MD Cardiologist AIHP, ACCA, FACC Clinique Médicale.
STEMI-WRAP on Evidence-Based Management of STEMI: The Emergency Department Perspective Charles V. Pollack, Jr., M.A., M.D., FACEP, FAHA Professor and Chair,
BASE HOSPITAL GROUP ONTARIO Chapter 3 for 12 Lead Training -Precourse- Ontario Base Hospital Group Education Subcommittee 2008 TIME IS MUSCLE.
Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLAT elet Inhibition and patient O utcomes trial Outcomes in patients.
Dr Adeel Shahzad Dr Rod Stables (PI) Liverpool Heart and Chest Hospital Liverpool, UK H ow E ffective are A ntithrombotic T herapies in PPCI.
PROTECTION AMI Inhibition of -Protein Kinase C for Reduction of Infarct Size in Acute Myocardial Infarction A. Michael Lincoff, M.D. Director, C5Research.
WG 2010 1 Hellenic PCI Registry Organization - Structure - Directions - Initial Recordings Georgios I. Papaioannou, MD,